Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma.

作者: Masanobu Tsubaki , Yuzuru Yamazoe , Masashi Yanae , Takao Satou , Tatsuki Itoh

DOI: 10.1016/J.CYTO.2011.01.005

关键词:

摘要: The tumor microenvironment plays a critical role in modulating malignant behavior and can dramatically influence cancer treatment strategies. We investigated whether statins inhibit the expression of vascular endothelial growth factor (VEGF), basic fibroblast (bFGF), hepatocyte (HGF), transforming factor-β (TGF-β) mRNA mouse osteosarcoma cell line LM8. found that significantly inhibited expressions bFGF, HGF, TGF-β, TGF-β secretions at concentrations did not have antiproliferative effects on LM8 cells, but had no effect secretion VEGF. inhibition expression, was reversed when geranylgeranyl pyrophosphate (GGPP), an intermediate mevalonate pathway, used combination with statins. Furthermore, reduced membrane localization K-Ras, phosphorylated extracellular signal-regulated kinase 1/2 (ERK1/2), Akt. Our research indicates GGPP biosynthesis then signal transduction Ras/ERK Ras/Akt pathways, thereby inhibiting cells. These results suggest are potentially useful as anti-angiogenic agents for osteosarcoma.

参考文章(31)
Ricky W. Johnstone, Astrid A. Ruefli, Scott W. Lowe, Apoptosis: a link between cancer genetics and chemotherapy. Cell. ,vol. 108, pp. 153- 164 ,(2002) , 10.1016/S0092-8674(02)00625-6
David J. Waxman, Pamela S. Schwartz, Harnessing Apoptosis for Improved Anticancer Gene Therapy Cancer Research. ,vol. 63, pp. 8563- 8572 ,(2003)
Matthijs R. Graaf, Dick J. Richel, Cornelis J.F. van Noorden, Henk-Jan Guchelaar, Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer Cancer Treatment Reviews. ,vol. 30, pp. 609- 641 ,(2004) , 10.1016/J.CTRV.2004.06.010
Jason P Hatton, Milad Pooran, Chai-Fei Li, Chris Luzzio, Millie Hughes-Fulford, A Short Pulse of Mechanical Force Induces Gene Expression and Growth in MC3T3-E1 Osteoblasts via an ERK 1/2 Pathway Journal of Bone and Mineral Research. ,vol. 18, pp. 58- 66 ,(2003) , 10.1359/JBMR.2003.18.1.58
Masanobu Tsubaki, Chisato Kato, Minori Nishinobo, Mitsuhiko Ogaki, Takao Satou, Tatsuki Ito, Takashi Kusunoki, Kimiko Fujiwara, Yuzuru Yamazoe, Shozo Nishida, Nitrogen-containing bisphosphonate, YM529/ONO-5920, inhibits macrophage inflammatory protein 1α expression and secretion in mouse myeloma cells Cancer Science. ,vol. 0, pp. 071104195727002- ??? ,(2007) , 10.1111/J.1349-7006.2007.00651.X
Michael A. Morgan, Tarkan Sebil, Erdem Aydilek, Dietrich Peest, Arnold Ganser, Christoph W. M. Reuter, Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells. British Journal of Haematology. ,vol. 130, pp. 912- 925 ,(2005) , 10.1111/J.1365-2141.2005.05696.X
Shozo Nishida, Hiroshi Matsuoka, Masanobu Tsubaki, Yoshihiro Tanimori, Masasi Yanae, Yoshiki Fujii, Masahiro Iwaki, Mevastatin induces apoptosis in HL60 cells dependently on decrease in phosphorylated ERK. Molecular and Cellular Biochemistry. ,vol. 269, pp. 109- 114 ,(2005) , 10.1007/S11010-005-3086-0
J??rgen Sonnemann, Vera Eckervogt, Borna Truckenbrod, Joachim Boos, Winfried Winkelmann, Frans van Valen, The bisphosphonate pamidronate is a potent inhibitor of Ewing's sarcoma cell growth in vitro Anti-Cancer Drugs. ,vol. 12, pp. 767- 771 ,(2001) , 10.1097/00001813-200310000-00013